Decide at what price you'd be comfortable buying and we'll help you stay ready.
ITW’s multi-year record pairs gradual revenue growth with expanding operating margins and consistently positive free cash flow. Plant spending has remained modest relative to cash generation, leaving room for dividends and share repurchases.
The latest quarter showed renewed organic growth and further margin expansion, while free cash flow remained positive. This improves the recent operating trajectory without yet changing the established cash-generative, relatively low-capital-intensity profile.
Whether organic growth broadens beyond capex-linked segments while the expanded operating margin is maintained.
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2B | 1.7B | 2.6B | 2.5B | 2.1B | 2.7B | 3B | 3B | 3.5B | 3.1B | |
| 470m | 462m | 461m | 426m | 427m | 410m | 410m | 395m | 402m | 397m | |
| (263m) | 64m | 34m | 32m | (30m) | (148m) | (150m) | (88m) | (176m) | (17m) | |
| 39m | 36m | 40m | 41m | 42m | 53m | 63m | 69m | 61m | 69m | |
| 23m | 31m | 41m | (12m) | 51m | 40m | (128m) | 67m | (414m) | 86m | |
| 920m | 1B | 838m | 742m | 591m | 731m | 993m | 1B | 1.2B | 1.1B | |
| 212m | 240m | 247m | 223m | 194m | 197m | 199m | 260m | 248m | 279m | |
| 37m | 158m | (288m) | 28m | 250m | (439m) | (818m) | 208m | (19m) | (406m) | |
| 2.3B | 2.4B | 2.8B | 3B | 2.8B | 2.6B | 2.3B | 3.5B | 3.3B | 3.1B | |
| (273m) | (297m) | (364m) | (326m) | (236m) | (296m) | (412m) | (455m) | (437m) | (419m) | |
| (259m) | 46m | 39m | 143m | 22m | (688m) | 302m | 52m | 293m | (102m) | |
| (532m) | (251m) | (325m) | (183m) | (214m) | (984m) | (110m) | (403m) | (144m) | (521m) | |
| (1.9B) | (916m) | (2B) | (1.4B) | (640m) | (950m) | (1.7B) | (1.4B) | (1.4B) | (1.4B) | |
| 465m | 197m | (851m) | 422m | (4m) | (141m) | 276m | 294m | (8m) | 508m | |
| (821m) | (941m) | (1.1B) | (1.3B) | (1.4B) | (1.5B) | (1.5B) | (1.6B) | (1.7B) | (1.8B) | |
| 17m | (14m) | (11m) | (12m) | (26m) | (10m) | (13m) | (14m) | (38m) | (32m) | |
| (2.3B) | (1.7B) | (4B) | (2.3B) | (2B) | (2.6B) | (3B) | (2.8B) | (3.2B) | (2.7B) | |
| (133m) | 145m | (112m) | (9m) | 39m | (46m) | (57m) | 3m | (65m) | 42m | |
| (618m) | 622m | (1.6B) | 477m | 583m | (1B) | (819m) | 357m | (117m) | (97m) | |
| 2B | 2.1B | 2.4B | 2.7B | 2.6B | 2.3B | 1.9B | 3.1B | 2.8B | 2.7B |
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more